So far 15 patients underwent surgery in the proof-of-concept study, according to an Oct. 17 news release.
“This is an important goal for the study: addressing the need for non-narcotic pain management therapy earlier on to avert the need for opioids,” Rohan Lall, MD, a co-investigator on the study, said in the release. “If the SynerFuse e-TLIF procedure proves effective at lowering post-operative pain levels, as early indications have suggested, we may have a new treatment strategy that potentially saves the healthcare system billions of dollars and improves pain management outcomes.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
